世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
世界のヒトミルクオリゴ糖（HMO）市場の洞察と2028年までの予測Global Human Milk Oligosaccharides (HMO) Market Insights and Forecast to 2028 ヒトミルクオリゴ糖（HMO）は、ヒトの乳児には消化できないにもかかわらず、ヒト母乳中に存在する構造的に多様な非共役糖鎖のファミリーであり、ヒト母乳に特有の糖鎖です。HMOは、常在菌の定着に役立つプレバイ... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーヒトミルクオリゴ糖（HMO）は、ヒトの乳児には消化できないにもかかわらず、ヒト母乳中に存在する構造的に多様な非共役糖鎖のファミリーであり、ヒト母乳に特有の糖鎖です。HMOは、常在菌の定着に役立つプレバイオティクスとして機能します。HMOはまた、粘膜表面への微生物病原体の付着を防止するのを助ける抗接着剤としても機能します。ヒトミルクオリゴ糖は、いくつかの化学物質、酵素または微生物の使用を含む多くのプロセスを通じて製造されています。ヒト乳オリゴ糖の製造に使用される技術は非常に複雑で高価であるため、その大規模生産には制約がある。主要企業は、低コストの生産と製品合成のための効果的な技術の導入のための研究開発にますます投資を増やしています。市場分析および洞察。世界のヒトミルクオリゴ糖 (HMO) 市場 COVID-19の大流行により、世界のヒトミルクオリゴ糖（HMO）市場規模は2022年に4億1110万米ドルと推定され、レビュー期間中にCAGR16.8％で2028年までに1億4370万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年に人乳オリゴ糖（HMO）世界市場の％を占める2'-FLおよび3-FLは、2028年までに100万米ドルの価値を持ち、ポストCOVID-19期間に修正された％のCAGRで成長すると予測されます。乳児用粉ミルクのセグメントは、この予測期間を通して％CAGRに変更されている一方で。 世界のヒトミルクオリゴ糖（HMO）中核メーカーには、Abbott、Glycomなどがあり、上位2社で約70％のシェアを占めています。 世界のヒトミルクオリゴ糖(HMO)のスコープとセグメント 人乳オリゴ糖 (HMO) 市場は、タイプ別および用途別に区分されます。世界のヒト乳オリゴ糖（HMO）市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別および用途別の売上高、収益、予測に焦点を当てています。 タイプ別セグメント 2'-FL & 3-FL シアリルラクトース LNT & LNnT 用途別セグメント 乳児用調製粉乳 機能性食品・飲料 食品・医療用サプリメント その他 会社別 アボット社 インビオース グライコム Chr.Hansen (Jennewein) エリシテルSA ズーケム デクストラ・ラボラトリーズ 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋地域 中国 日本 韓国 インド オーストラリア 台湾 インドネシア タイ マレーシア フィリピン ベトナム 中南米 メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア U.A.E. 目次1 Study Coverage1.1 Human Milk Oligosaccharides (HMO) Product Introduction 1.2 Market by Type 1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 2'-FL & 3-FL 1.2.3 Sialyllactose 1.2.4 LNT & LNnT 1.3 Market by Application 1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Infant Formula 1.3.3 Functional Food & Beverages 1.3.4 Food/Medical Supplements 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2017-2028 2.2 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Milk Oligosaccharides (HMO) Sales by Region 2.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) 2.4.2 Global Sales Human Milk Oligosaccharides (HMO) by Region (2023-2028) 2.5 Global Human Milk Oligosaccharides (HMO) Revenue by Region 2.5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022) 2.5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers 3.1.1 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Sales (2017-2022) 3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Milk Oligosaccharides (HMO) in 2021 3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers 3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2021 3.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type 4.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Type (2017-2022) 4.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028) 4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type 4.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Type (2017-2022) 4.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028) 4.3 Global Human Milk Oligosaccharides (HMO) Price by Type 4.3.1 Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022) 4.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application 5.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Application (2017-2022) 5.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028) 5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application 5.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Application (2017-2022) 5.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028) 5.3 Global Human Milk Oligosaccharides (HMO) Price by Application 5.3.1 Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022) 5.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028) 6 North America 6.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type 6.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 6.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 6.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application 6.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 6.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country 6.3.1 North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 6.3.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type 7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 7.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 7.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application 7.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 7.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country 7.3.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Type 8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 8.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Application 8.2.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 8.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Region 8.3.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Type 9.1.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 9.1.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 9.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Application 9.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 9.2.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 9.3 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country 9.3.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 9.3.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Type 10.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Application 10.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country 10.3.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Overview 11.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Abbott Recent Developments 11.2 Inbiose 11.2.1 Inbiose Corporation Information 11.2.2 Inbiose Overview 11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Inbiose Recent Developments 11.3 Glycom 11.3.1 Glycom Corporation Information 11.3.2 Glycom Overview 11.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Glycom Recent Developments 11.4 Chr. Hansen (Jennewein) 11.4.1 Chr. Hansen (Jennewein) Corporation Information 11.4.2 Chr. Hansen (Jennewein) Overview 11.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Chr. Hansen (Jennewein) Recent Developments 11.5 Elicityl SA 11.5.1 Elicityl SA Corporation Information 11.5.2 Elicityl SA Overview 11.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Elicityl SA Recent Developments 11.6 ZuChem 11.6.1 ZuChem Corporation Information 11.6.2 ZuChem Overview 11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 ZuChem Recent Developments 11.7 Dextra Laboratories 11.7.1 Dextra Laboratories Corporation Information 11.7.2 Dextra Laboratories Overview 11.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Dextra Laboratories Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Human Milk Oligosaccharides (HMO) Industry Chain Analysis 12.2 Human Milk Oligosaccharides (HMO) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Milk Oligosaccharides (HMO) Production Mode & Process 12.4 Human Milk Oligosaccharides (HMO) Sales and Marketing 12.4.1 Human Milk Oligosaccharides (HMO) Sales Channels 12.4.2 Human Milk Oligosaccharides (HMO) Distributors 12.5 Human Milk Oligosaccharides (HMO) Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Milk Oligosaccharides (HMO) Industry Trends 13.2 Human Milk Oligosaccharides (HMO) Market Drivers 13.3 Human Milk Oligosaccharides (HMO) Market Challenges 13.4 Human Milk Oligosaccharides (HMO) Market Restraints 14 Key Findings in The Global Human Milk Oligosaccharides (HMO) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
SummaryHuman milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis. Table of Contents1 Study Coverage1.1 Human Milk Oligosaccharides (HMO) Product Introduction 1.2 Market by Type 1.2.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 2'-FL & 3-FL 1.2.3 Sialyllactose 1.2.4 LNT & LNnT 1.3 Market by Application 1.3.1 Global Human Milk Oligosaccharides (HMO) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Infant Formula 1.3.3 Functional Food & Beverages 1.3.4 Food/Medical Supplements 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Human Milk Oligosaccharides (HMO) Sales Estimates and Forecasts 2017-2028 2.2 Global Human Milk Oligosaccharides (HMO) Revenue Estimates and Forecasts 2017-2028 2.3 Global Human Milk Oligosaccharides (HMO) Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Human Milk Oligosaccharides (HMO) Sales by Region 2.4.1 Global Human Milk Oligosaccharides (HMO) Sales by Region (2017-2022) 2.4.2 Global Sales Human Milk Oligosaccharides (HMO) by Region (2023-2028) 2.5 Global Human Milk Oligosaccharides (HMO) Revenue by Region 2.5.1 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2022) 2.5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Human Milk Oligosaccharides (HMO) Sales by Manufacturers 3.1.1 Global Top Human Milk Oligosaccharides (HMO) Manufacturers by Sales (2017-2022) 3.1.2 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Milk Oligosaccharides (HMO) in 2021 3.2 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers 3.2.1 Global Human Milk Oligosaccharides (HMO) Revenue by Manufacturers (2017-2022) 3.2.2 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Human Milk Oligosaccharides (HMO) Revenue in 2021 3.3 Global Human Milk Oligosaccharides (HMO) Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Human Milk Oligosaccharides (HMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Human Milk Oligosaccharides (HMO) Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Human Milk Oligosaccharides (HMO) Sales by Type 4.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Type (2017-2022) 4.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Type (2023-2028) 4.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Type (2017-2028) 4.2 Global Human Milk Oligosaccharides (HMO) Revenue by Type 4.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Type (2017-2022) 4.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Type (2023-2028) 4.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Type (2017-2028) 4.3 Global Human Milk Oligosaccharides (HMO) Price by Type 4.3.1 Global Human Milk Oligosaccharides (HMO) Price by Type (2017-2022) 4.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Type (2023-2028) 5 Market Size by Application 5.1 Global Human Milk Oligosaccharides (HMO) Sales by Application 5.1.1 Global Human Milk Oligosaccharides (HMO) Historical Sales by Application (2017-2022) 5.1.2 Global Human Milk Oligosaccharides (HMO) Forecasted Sales by Application (2023-2028) 5.1.3 Global Human Milk Oligosaccharides (HMO) Sales Market Share by Application (2017-2028) 5.2 Global Human Milk Oligosaccharides (HMO) Revenue by Application 5.2.1 Global Human Milk Oligosaccharides (HMO) Historical Revenue by Application (2017-2022) 5.2.2 Global Human Milk Oligosaccharides (HMO) Forecasted Revenue by Application (2023-2028) 5.2.3 Global Human Milk Oligosaccharides (HMO) Revenue Market Share by Application (2017-2028) 5.3 Global Human Milk Oligosaccharides (HMO) Price by Application 5.3.1 Global Human Milk Oligosaccharides (HMO) Price by Application (2017-2022) 5.3.2 Global Human Milk Oligosaccharides (HMO) Price Forecast by Application (2023-2028) 6 North America 6.1 North America Human Milk Oligosaccharides (HMO) Market Size by Type 6.1.1 North America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 6.1.2 North America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 6.2 North America Human Milk Oligosaccharides (HMO) Market Size by Application 6.2.1 North America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 6.2.2 North America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 6.3 North America Human Milk Oligosaccharides (HMO) Market Size by Country 6.3.1 North America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 6.3.2 North America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Human Milk Oligosaccharides (HMO) Market Size by Type 7.1.1 Europe Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 7.1.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 7.2 Europe Human Milk Oligosaccharides (HMO) Market Size by Application 7.2.1 Europe Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 7.2.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 7.3 Europe Human Milk Oligosaccharides (HMO) Market Size by Country 7.3.1 Europe Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 7.3.2 Europe Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Type 8.1.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 8.1.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 8.2 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Application 8.2.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 8.2.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 8.3 Asia Pacific Human Milk Oligosaccharides (HMO) Market Size by Region 8.3.1 Asia Pacific Human Milk Oligosaccharides (HMO) Sales by Region (2017-2028) 8.3.2 Asia Pacific Human Milk Oligosaccharides (HMO) Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Human Milk Oligosaccharides (HMO) Market Size by Type 9.1.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 9.1.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 9.2 Latin America Human Milk Oligosaccharides (HMO) Market Size by Application 9.2.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 9.2.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 9.3 Latin America Human Milk Oligosaccharides (HMO) Market Size by Country 9.3.1 Latin America Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 9.3.2 Latin America Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Type 10.1.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Type (2017-2028) 10.1.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Type (2017-2028) 10.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Application 10.2.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Application (2017-2028) 10.2.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Application (2017-2028) 10.3 Middle East and Africa Human Milk Oligosaccharides (HMO) Market Size by Country 10.3.1 Middle East and Africa Human Milk Oligosaccharides (HMO) Sales by Country (2017-2028) 10.3.2 Middle East and Africa Human Milk Oligosaccharides (HMO) Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Corporation Information 11.1.2 Abbott Overview 11.1.3 Abbott Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Abbott Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Abbott Recent Developments 11.2 Inbiose 11.2.1 Inbiose Corporation Information 11.2.2 Inbiose Overview 11.2.3 Inbiose Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Inbiose Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Inbiose Recent Developments 11.3 Glycom 11.3.1 Glycom Corporation Information 11.3.2 Glycom Overview 11.3.3 Glycom Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Glycom Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Glycom Recent Developments 11.4 Chr. Hansen (Jennewein) 11.4.1 Chr. Hansen (Jennewein) Corporation Information 11.4.2 Chr. Hansen (Jennewein) Overview 11.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Chr. Hansen (Jennewein) Recent Developments 11.5 Elicityl SA 11.5.1 Elicityl SA Corporation Information 11.5.2 Elicityl SA Overview 11.5.3 Elicityl SA Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Elicityl SA Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Elicityl SA Recent Developments 11.6 ZuChem 11.6.1 ZuChem Corporation Information 11.6.2 ZuChem Overview 11.6.3 ZuChem Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 ZuChem Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 ZuChem Recent Developments 11.7 Dextra Laboratories 11.7.1 Dextra Laboratories Corporation Information 11.7.2 Dextra Laboratories Overview 11.7.3 Dextra Laboratories Human Milk Oligosaccharides (HMO) Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Dextra Laboratories Human Milk Oligosaccharides (HMO) Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Dextra Laboratories Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Human Milk Oligosaccharides (HMO) Industry Chain Analysis 12.2 Human Milk Oligosaccharides (HMO) Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Human Milk Oligosaccharides (HMO) Production Mode & Process 12.4 Human Milk Oligosaccharides (HMO) Sales and Marketing 12.4.1 Human Milk Oligosaccharides (HMO) Sales Channels 12.4.2 Human Milk Oligosaccharides (HMO) Distributors 12.5 Human Milk Oligosaccharides (HMO) Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Human Milk Oligosaccharides (HMO) Industry Trends 13.2 Human Milk Oligosaccharides (HMO) Market Drivers 13.3 Human Milk Oligosaccharides (HMO) Market Challenges 13.4 Human Milk Oligosaccharides (HMO) Market Restraints 14 Key Findings in The Global Human Milk Oligosaccharides (HMO) Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（飲料）の最新刊レポートQYResearch社の飲料分野での最新刊レポート
本レポートと同じKEY WORD（milk）の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
